Parkinson’s, unhealthy which distress as many 10 million people in the world, seek is done by a depletion of dopamine-producing nerve cells in the genius. Typically in Parkinson’s disease, people lose the capability to produce dopamine, a neurotransmitter that is linked with reward and excitement and support, but most decisively with movement. Simply put, when we lose dopamine we cannot go and become prey to a whole range of problems linked to movement, like tremors, poor posture, awkward gait and imbalance.
Despite massive global efforts, Parkinson’s disease continues to resist a cure. Best, the patients can hope for currently is reprieve from its crippling symptoms with drugs and brain stimulation or electrical implants. Current medication for Parkinson’s including the drug Levodopa, which was revealed in the 1960s. It is changed into dopamine in the body, and then it behaves as a stand-in for the lost dopamine-making nerve cells. Close to other drugs act like dopamine to stimulate the nerve cells. Patients are moreover prescribed with healthy diet, physical exercise, occupational or physiotherapy. Surgical procedure, like deep brain stimulation with implanted electrodes, is practiced to treat more advanced examples, especially in those where the drugs are going less fighting fit. These treatments relieve the symptoms of Parkinson’s disease, but do not turn over the damage to nerve cells in the psyche. Over time, the clinical features get worse and have severe adverse effects despite treatment.
There is, nevertheless, more or less good news pointing to a possible cure involving transplantation of stem cells to restore damaged brain regions. This is an important breakthrough in the guidance of understanding how stem cells might silhouette future Parkinson’s treatments. The answers from clinical trial study have validated that first, it is potential to safely administer in the treatment and second, doing so yields positive outcomes. In a trial for chronic Parkinson’s patients those who were not responding to conservative therapies, recovered many of their motor functions. Parkinson’s is a dependable prospect for a stem cell therapy because the majority of motor deficiencies relate clearly to one specific– cell-the dopamine neuron. Stem cells possess an unparalleled regenerative capacity and can also release many different support factors. Scientists are counting at two major ways of using stem cells for Parkinson’s treatment: as factories to mass-produce dopamine neurons or as a source of development factors to protect nerve cells.
The stem cell treatment available at Advancells is designed to target damaged neurons and to help with the conception of new dopamine producing neurons. Upon transplantation, stem cells which are harvested from body’s own Bone marrow or fat tissue may release innate chemicals called cytokines which can induce differentiation of the stem cells into dopamine producing neurons, thus heal the damage. Using stem cells to treat Parkinson’s is a realistic possibility.